Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2010
12/16/2010US20100317715 Methods for treating neuropsychiatric conditions
12/16/2010US20100317714 Complex molecule interfering the expression of target genes and its preparing methods
12/16/2010US20100317713 Micro-rnas of the mir-15 family modulate cardiomyocyte survival and cardiac repair
12/16/2010US20100317712 Estrogen Agonists/Antagonists For Preventing Breast Cancer
12/16/2010US20100317711 Stem-like cells and method for reprogramming adult mammalian somatic cells
12/16/2010US20100317710 3-(3-indolyl) propionic acid calcium salt and method of making 3-(3-indolyl) propionic acid free acid therefrom
12/16/2010US20100317709 Sphingosine-1-phosphate (s1p) receptor compounds
12/16/2010US20100317708 Carcinoma diagnosis and treatment, based on odc1 genotype
12/16/2010US20100317707 Oligomer-Nitroimidazole Anti-Infective Conjugates
12/16/2010US20100317706 HNF4alpha MODULATORS AND METHODS OF USE
12/16/2010US20100317705 Oligomer-Dantrolene Conjugates and Related Compounds
12/16/2010US20100317704 Spiro-condensed imidazolone derivatives inhibiting the glycine transporter
12/16/2010US20100317702 Crystalline form of febuxostat
12/16/2010US20100317701 Heterocyclic inhibitors of necroptosis
12/16/2010US20100317699 Use of hedgehog agonists in the treatment of musculoskeletal-related disorders
12/16/2010US20100317698 Polysubstituted Pyridinylaminoalkylene- and Pyridinyloxyalkylene-Cyclopropanamine Compounds, a Process for Their Preparation and Pharmaceutical Compositions Containing Them
12/16/2010US20100317697 Renin Inhibitors
12/16/2010US20100317696 Iminosugars and methods of treating bunyaviral and togaviral diseases
12/16/2010US20100317695 Gel composition for treating mycosis
12/16/2010US20100317694 Solid pharmaceutical composition comprising donepezil hydrochloride
12/16/2010US20100317693 3,8-diaminotetrahydroquinoline derivative
12/16/2010US20100317692 Quinolone M1 Receptor Positive Allosteric Modulators
12/16/2010US20100317691 Isoquinolone compounds as subtype-selective agonists for melatonin receptors mt1 and mt2
12/16/2010US20100317690 Treatment of protein folding disorders
12/16/2010US20100317689 Prodrugs of proton pump inhibitors including the 1h-imidazo[4,5-b] pyridine moiety
12/16/2010US20100317688 2-HETEROAROYLIMIDAZOL[1,2-a]PYRIDINE DERIVATIVES, PREPARATION AND THERAPEUTIC USE THEREOF
12/16/2010US20100317687 2-BENZOYLIMIDAZO[1,2-a]PYRIDINE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF
12/16/2010US20100317686 N-HETEROCYCLIC-6-HETEROCYCLIC-IMIDAZO[1,2-a]PYRIDINE-2-CARBOXAMIDE DERIVATIVES, PREPARATION AND THERAPEUTIC USE THEREOF
12/16/2010US20100317685 N-PHENYL-IMIDAZO[1,2-a]PYRIDINE-2-CARBOXAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
12/16/2010US20100317684 Amide and Carbamate Derivatives of N-{2-[4-Amino-2- (Ethoxymethyl)-1H-Imidazo[4,5-c] Quinolin-1-Yl]-1,1-Dimethylethyl} Methanesulfonamide and Methods
12/16/2010US20100317683 Preparation of 6-Alpha-Amino N-Substituted Morphinans by Catalytic Hydrogen Transfer
12/16/2010US20100317682 Single Dosage Unit Including Opioid and Methylnaltrexone or Methylnaltrexone Salt
12/16/2010US20100317681 Modulation of systemic exposure to rifaximin
12/16/2010US20100317680 Pyrimidine inhibitors of kinases
12/16/2010US20100317679 Substituted aryl-fused spirocyclic amines
12/16/2010US20100317678 Hydroxamates as inhibitors of histone deacetylase
12/16/2010US20100317677 Methods of Treating a Microbial Infection by Modulating RNase-L Expression and/or Activity
12/16/2010US20100317676 Fused heterocyclic compounds, and compositions and uses thereof
12/16/2010US20100317675 6-HETEROCYCLIC-IMIDAZO[1,2-a]PYRIDINE-2-CARBOXAMIDE DERIVATIVES, PREPARATION AND THERAPEUTIC USE THEREOF
12/16/2010US20100317674 Metabotropic Glutamate-Receptor-Potentiating Isoindolones
12/16/2010US20100317673 N-HETEROCYCLIC-IMIDAZO[1,2-a]PYRIDINE-2-CARBOXAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
12/16/2010US20100317672 Monomaleate Monohydrate Salt of a 5HT1A Receptor Antagonist
12/16/2010US20100317671 Xanthine-based cyclic gmp-enhancing rho-kinase inhibitor inhibits physiological activities of lung epithelial cell line
12/16/2010US20100317670 Therapeutic agents useful for treating pain
12/16/2010US20100317669 Novel substituted piperidyl-propane-thiols
12/16/2010US20100317668 Substituted pyrano [2,3-b] pyridinamine compounds as beta-secretase modulators and methods of use
12/16/2010US20100317667 1-aryl-or 1-heteroaryl-pyrido[B]indoles and uses thereof
12/16/2010US20100317666 Composition Comprising An NK-1 Receptor Antagonist And An SSRI For The Treatment Of Tinnitus And Hearing Loss
12/16/2010US20100317665 Anti-Inflammatory And Protein Kinase Inhibitor Compositions And Related Methods For Downregulation Of Detrimental Cellular Responses And Inhibition Of Cell Death
12/16/2010US20100317664 Methods of affecting gastrointestinal transit and gastric emptying, and compounds useful therein
12/16/2010US20100317663 Anilinopyridines as inhibitors of fak
12/16/2010US20100317662 Metabotropic Glutamate Receptor Isoxazole Ligands and Their Use as Potentiators - 286
12/16/2010US20100317661 Small molecule inhibitors of mdm2 and the uses thereof
12/16/2010US20100317660 Mediators of hedgehog signaling pathways, compositions and uses related thereto
12/16/2010US20100317659 Jak kinase modulating compounds and methods of use thereof
12/16/2010US20100317658 4,7-Dioxobenzothiazole-2-Carboxamide Derivatives, Their Preparation And Their Therapeutic Uses
12/16/2010US20100317657 1H-IMIDAZO[4,5-c]QUINOLINONE DERIVATIVES
12/16/2010US20100317656 IMIDAZO[1,2-a]PYRIDINE-2-CARBOXAMIDE DERIVATIVES, PREPARATION THEREOF AND APPLICATION THEREOF IN THERAPEUTICS
12/16/2010US20100317655 Sulfonamide inhibitors of carbonic anhydrase
12/16/2010US20100317654 1,4-diaza-bicyclo[3.2.2]nonyl oxadiazolyl derivatives and their medical use
12/16/2010US20100317653 Oxadiazole derivatives as dgat inhibitors
12/16/2010US20100317652 Compounds Useful In Therapy
12/16/2010US20100317651 Pyrazinooxazepine derivatives
12/16/2010US20100317650 Imidazopyridine derivatives useful as inos inhibitors
12/16/2010US20100317649 S1P Receptor Modulating Compounds and Use Thereof
12/16/2010US20100317648 Therapeutic compounds
12/16/2010US20100317647 Novel cyclopentane derivatives
12/16/2010US20100317646 Compounds
12/16/2010US20100317645 Substituted diazepine sulfonamides as bombesin receptor subtype-1 modulators
12/16/2010US20100317644 Substituted Sulfonamide Compounds
12/16/2010US20100317643 Janus kinase inhibitor compounds and methods
12/16/2010US20100317642 Pharmaceutical composition of orlistat
12/16/2010US20100317641 Thiazoles and pyrazoles useful as kinase inhibitors
12/16/2010US20100317639 Medicament Based On a Monoester of Steroids With Long Chain Fatty Acids
12/16/2010US20100317638 Neuroactive 13,24-Cyclo-18,21-Dinorcholanes and Structurally Related Pentacylic Steroids
12/16/2010US20100317637 Anti-hepatitis c composition and method for preparing drug for inhibiting hepatitis c viruses or treating hepatitis c
12/16/2010US20100317636 Reducing the risk of chronic lung disease in infants
12/16/2010US20100317635 Treatment of hot flushes, vasomotor symptoms, and night sweats with sex steroid precursors in combination with selective estrogen receptor modulators
12/16/2010US20100317634 Piperidyl-propane-thiol ccr3 modulators
12/16/2010US20100317633 Hexahydro-cyclooctyl pyrazole cannabinoid modulators
12/16/2010US20100317632 17-(1'propenyl)-17-3'-oxidoestra-4-en-3-one derivative, use thereof, and medicament containing said derivative
12/16/2010US20100317631 Gel Composition and Transcrotal Application of a Composition for the Treatment of Hypogonadism
12/16/2010US20100317630 Novel heterocyclic compounds as mglu5 antagonists
12/16/2010US20100317629 Dissolvable pharmaceutical implant
12/16/2010US20100317628 MicroRNA Modulators and Method for Identifying and Using the Same
12/16/2010US20100317627 Treatment of HCV Disorders
12/16/2010US20100317626 The Use Of (3-Amino-2-Fluoropropyl) Phosphinic Acid For Treatment Of NERD
12/16/2010US20100317625 Novel sulfonamidomethylphosphonate inhibitors of beta-lactamase
12/16/2010US20100317624 Heterocyclic urea derivatives and methods of use thereof
12/16/2010US20100317623 HCV NS3 Protease Inhibitors
12/16/2010US20100317622 Producing Method of Phospholipids Including Long-Chain Polyunsaturated Fatty Acids as Constituents, and Use of Such Phospholipids
12/16/2010US20100317621 Beta-lactamase inhibitors
12/16/2010US20100317620 N-PHENYLIMIDAZO[1,2-a]PYRIDINE-2-CARBOXAMIDE COMPOUNDS, PREPARATION AND THERAPEUTIC USE THEREOF
12/16/2010US20100317619 Selective Agents for Pain Suppression
12/16/2010US20100317618 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1 and cx3cr1
12/16/2010US20100317617 Silver nanoparticles as anti-microbial
12/16/2010US20100317616 Alkylated semi-synthetic glycosaminoglycan ethers, and methods of making and using thereof
12/16/2010US20100317615 Method of enhancing ocular penetration of a drug in an eyedrop
12/16/2010US20100317613 Activity enhancer for detoxifying enzyme
12/16/2010US20100317612 Method of obtaining of 4-n-furfurylcytosine and/or its derivatives, an anti-aging composition and use of 4-n-furfurylcytosine and/or its derivatives in the manufacture of anti-aging composition
1 ... 1954 1955 1956 1957 1958 1959 1960 1961 1962 1963 1964 1965 1966 1967 1968 1969 1970 1971 1972 1973 1974 ... 7860